Social Media Is Fueling Enthusiasm for New Weight Loss Drugs. Are Regulators Watching?
Online platforms are overflowing with testimonials for GLP-1s. The drugs show promise for inducing weight loss, but many aren鈥檛 FDA-approved for that use.
Diabetes
21 - 40 of 120 Results
-
The Confusing Fate of the Abortion Pill
Episode 293The legality and availability of the abortion pill mifepristone is in question after a federal judge in Texas canceled the FDA鈥檚 approval of the first drug used in the two-drug medication abortion regimen. A 5th Circuit Court of Appeals panel overruled that decision in part, saying the pill should remain available, but only under the onerous restrictions in place before 2016. Meanwhile, another federal judge in Washington state issued a ruling in a separate case that conflicts with the Texas decision, ordering the FDA not to roll back any of its restrictions on the drug. Victoria Knight of Axios, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join 黑料吃瓜网 News chief Washington correspondent Julie Rovner to discuss these issues and more.
-
Montana May Require Insurers to Cover Monitoring Devices for Diabetes
Montana is one of several states considering expanding coverage of continuous glucose monitors, but insurance companies and some providers argue that not all people with diabetes need them.
By Keely Larson -
Journalists Delve Into Insulin Costs and Prior Authorization Policy
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here鈥檚 a collection of their appearances.
-
Fresh Produce Is an Increasingly Popular Prescription for Chronically Ill Patients
Fresh produce prescription programs are getting a boost in Montana as a way of helping people with chronic conditions such as diabetes and high blood pressure. The approach may be a model for other rural states to promote healthy eating in food deserts.
By Carly Graf -
California Picks Generic Drug Company Civica to Produce Low-Cost Insulin
Gov. Gavin Newsom, who blasted pharmaceutical companies for gouging Californians, is moving ahead with state-branded insulin. He鈥檚 also eyeing other generic drugs.
By Angela Hart -
Why Does Insulin Cost So Much? Big Pharma Isn鈥檛 the Only Player Driving Prices
Big Pharma may be moving on from squeezing diabetes patients on insulin prices, but it鈥檚 the arbitrators that jack up prices for those who can least afford them.
By Arthur Allen -
Journalists Discuss Insulin Prices, Gun Violence, Distracted Driving, and More
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here鈥檚 a collection of their appearances.
-
Eli Lilly Slashed Insulin Prices. This Starts a Race to the Bottom.
Eli Lilly's news that it plans to cut insulin costs for patients will help, not hinder, the recent efforts in California and by entrepreneurs such as Mark Cuban to offer lower-cost alternatives, drug pricing experts said.
By Bram Sable-Smith and Samantha Young -
Armed With Hashtags, These Activists Made Insulin Prices a Presidential Talking Point
Twitter has been a hotbed for the burgeoning insulin access movement and activism surrounding other medical conditions. For people with diabetes, the platform has helped propel concern about insulin prices into policy. Can it continue to win with hashtags?
-
California Attorney General Sues Drugmakers Over Inflated Insulin Prices
California Attorney General Rob Bonta is taking three major drugmakers and three distributors to court, alleging the companies illegally raised prices at the expense of diabetes patients.
By Angela Hart and Samantha Young -
A Retiree Returns to Work After a Calamitous Year of Health Emergencies
In 2020, diabetes and covid-19 landed David Zipprich in the hospital three times. Even with insurance, he was inundated with bills, debt notices, and calls from collectors.
-
Watch: The Politics of Health Care in California
KHN senior correspondent Angela Hart discussed the most pressing health care issues in California with the nonpartisan group Democracy Winters in mid-November, touching on a variety of issues, from the state鈥檚 effort to transform its Medicaid program to its plan to produce generic insulin.
-
Medicare Plan Finder Likely Won鈥檛 Note New $35 Cap on Out-of-Pocket Insulin Costs
In August, Congress approved a $35 cap on what seniors will pay for insulin, but that change came too late to add to the online tool that helps Medicare beneficiaries compare dozens of drug and medical plans. Federal officials say beneficiaries who use insulin will have the opportunity to switch plans after open enrollment ends Dec. 7.
By Susan Jaffe -
Weight Loss Gadgets: They Provide Data to Help Consumers Achieve Diet Goals, but It Still Won鈥檛 Be Easy
You may have seen the ads that promise weight loss and better health 鈥 phone apps, rings, and other devices 鈥 by giving you data on how your body reacts to food, exercise, and sleep. Is this information enough to help consumers achieve their goals?
-
鈥楢n Arm and a Leg鈥: Checking Up on California鈥檚 DIY Insulin Project
California put up $100 million to produce its own insulin. How did this plan come to be, and what might stand in the state鈥檚 way?
-
BMI: The Mismeasure of Weight and the Mistreatment of Obesity
The human body mass index 鈥 a simple mathematical equation 鈥 is tied to a measure of obesity invented almost 200 years ago. On the downside, it can stand between patients and treatment for weight issues. It particularly mismeasures Black women and Asians.
-
Congressman鈥檚 Wife Died After Taking Herbal Remedy Marketed for Diabetes and Weight Loss
Lori McClintock, the wife of U.S. Rep. Tom McClintock of California, died after ingesting white mulberry leaf, according to the Sacramento County coroner. The plant is generally considered safe and is used in herbal remedies that claim to lower blood sugar, boost weight loss, and combat high cholesterol. Her death highlights the potential dangers of dietary supplements.
-
Listen: Can California Lower the Price of Insulin?
California Healthline senior correspondent Angela Hart describes California鈥檚 ambitious plan to manufacture generic insulin under the state鈥檚 new 鈥淐alRx鈥 drug label.
-
Seniors With Prediabetes Should Eat Better, Get Moving, but Not Fret Too Much About Diabetes
About half of adults 65 and older have above-normal blood sugar levels that put them in the prediabetes category. Although that is a signal to improve your eating habits and get more exercise, researchers say only a small percentage of the group will develop diabetes.